Position in CRMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$320,743
+$180,951 QoQ
Shares Held
40,859
+98.5% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 194 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. CRMD ranks #267 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in CRMD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $320,743 | 40,859 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $139,792 | 20,588 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,106,262 | 181,106 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,495,094 | 128,555 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,904,984 | 316,963 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $172,172 | 27,950 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $255,060 | 31,489 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $212,504 | 26,300 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $678,666 | 156,736 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $267,056 | 62,985 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $668,294 | 177,738 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $845,853 | 228,609 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $155,227 | 39,100 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $418,484 | 99,167 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $331,896 | 117,278 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $815,907 | 202,962 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $394,154 | 71,926 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $477,113 | 104,860 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $601,049 | 129,258 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,363,082 | 198,700 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $1,132,101 | 152,369 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $446,979 | 74,126 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $342,253 | 54,326 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||